Walleye Capital’s Jade Biosciences JBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding JBIO
Walleye Capital's JBIO Position: Q3 2026 in Review
Walleye Capital reduced its Jade Biosciences (JBIO) stake by 51% in Q3 2026, selling an estimated $3.71M and leaving 180,462 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2596.
Walleye Capital first reported a position in JBIO in Q1 2024 and has held it in 3 quarters since. The position peaked at $8.12M in Q2 2026. 160 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.
- Walleye Capital held 180,462 shares of Jade Biosciences worth $2.54M as of Q3 2026.
- Walleye Capital sold 184,810 Jade Biosciences shares in Q3 2026, an estimated $3.71M.
- Jade Biosciences made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2596 holding.
- Walleye Capital first reported a position in Jade Biosciences in Q1 2024 and has held it in 3 quarters since.
- Walleye Capital's Jade Biosciences position peaked at $8.12M in Q2 2026.
- 160 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.